AUSTRALIA
The 2025 Pharmaceutical Patent Review
Welcome to Spruson & Ferguson’s review of the most notable developments in Australian pharmaceutical patent law in the past year. The year has seen a series of landmark decisions from...
Welcome to Spruson & Ferguson’s review of the most notable developments in Australian pharmaceutical patent law in the past...
Read More
SINGAPORE
Singapore | PPH Pilot offers partial refund for official fees
The Intellectual Property Office of Singapore (IPOS) has released a new initiative to support business entry into the Patent Prosecution Highway (PPH), with a pilot offering partial refund on...
The Intellectual Property Office of Singapore (IPOS) has released a new initiative to support business entry into the Patent...
Read More
AUSTRALIA
Australia and New Zealand | Guide to differences in patent prosecution
A side-by-side look at patent prosecution in Australia and New Zealand While both jurisdictions share common roots, namely the Statute of Monopolies 1623, the Australia and New Zealand patent systems...
A side-by-side look at patent prosecution in Australia and New Zealand While both jurisdictions share common roots, namely the Statute...
Read More
AUSTRALIA
Australia | Part 2: Regulatory considerations for orphan drugs
Following our first article on orphan drug development, which examined key patenting options and strategies, our second article sets out the key regulatory considerations in Australia. Orphan drug patent strategy...
Following our first article on orphan drug development, which examined key patenting options and strategies, our second article sets...
Read More
AUSTRALIA
Australia | Part 1: Patenting orphan drugs
Collectively, rare diseases impact approximately 8% of the Australian population, or around 2 million people. Orphan drugs are pharmaceutical products developed to treat rare diseases, however with each drug...
Collectively, rare diseases impact approximately 8% of the Australian population, or around 2 million people. Orphan drugs are pharmaceutical...
Read More
GREATER CHINA
China | Draft changes to dual filing in China
With double patenting prohibited in China, many applicants have utilised a dual filing strategy to secure patent rights, but this may be set to change. As noted in our article...
With double patenting prohibited in China, many applicants have utilised a dual filing strategy to secure patent rights, but...
Read More
GREATER CHINA
How divisional patent applications work in China
Chinese divisional practice is known for its unique timing requirements, prerequisites for filing a divisional, and strict procedural deadlines. For patent holders looking to secure their rights in China,...
Chinese divisional practice is known for its unique timing requirements, prerequisites for filing a divisional, and strict procedural deadlines....
Read More
AUSTRALIA
Australia | NSW Government grant for startups and innovative SMEs
The MVP Ventures 2025–2026 Program offers innovators in New South Wales a valuable opportunity to take their products closer to market. For early-stage innovators with a developed Minimum Viable Product...
The MVP Ventures 2025–2026 Program offers innovators in New South Wales a valuable opportunity to take their products closer...
Read More
AUSTRALIA
Australia | Federal Court launches Standard Directions to streamline patent disputes
A new Practice Note introduced by the Federal Court of Australia promises to facilitate more efficient and economical resolution of patent disputes in Australia. The complexities of patent litigation, including...
A new Practice Note introduced by the Federal Court of Australia promises to facilitate more efficient and economical resolution...
Read More
AUSTRALASIA
Breaking up is never easy – Brexit’s final bow
This year marks the final milestone of the Brexit trade mark transition.  After 31 December 2025, owners of an EU mark or a UK mark can no longer rely...
This year marks the final milestone of the Brexit trade mark transition.  After 31 December 2025, owners of an...
Read More

Find Your Expert

Experts

Contact Us

Enquiries

Receive Insights

Subscribe